Expression of a high molecular weight form of insulin-like growth factor II in a Beckwith-Wiedemann syndrome associated adrenocortical adenoma

Cancer Lett. 1995 Jul 20;94(1):71-7. doi: 10.1016/0304-3835(95)03826-i.

Abstract

Beckwith-Wiedemann syndrome is a rare condition (1/13,700 live births) occurring in both inherited and sporadic forms in the population. It is manifest as a fetal overgrowth syndrome, in which hypertrophy dominates the clinical picture. An additional complication is that these children are predisposed to a specific subset of childhood neoplasms, amongst which are Wilms' tumour and adrenocortical carcinoma. We report here the synthesis by an associated adrenal tumour of large quantities of a high molecular weight form of insulin-like growth factor II (IGF-II), associated with profound suppression of circulating IGFs in the patient's serum. As with other tumours of this type, the tumours showed loss of material on chromosome 11p.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / etiology
  • Adenoma / genetics
  • Adenoma / metabolism*
  • Adrenal Cortex Neoplasms / etiology
  • Adrenal Cortex Neoplasms / genetics
  • Adrenal Cortex Neoplasms / metabolism*
  • Beckwith-Wiedemann Syndrome / complications
  • Beckwith-Wiedemann Syndrome / metabolism*
  • Genotype
  • Humans
  • Infant
  • Insulin-Like Growth Factor II / chemistry
  • Insulin-Like Growth Factor II / metabolism*
  • Male
  • Molecular Weight
  • Neoplasm Proteins / chemistry
  • Neoplasm Proteins / metabolism*

Substances

  • Neoplasm Proteins
  • Insulin-Like Growth Factor II